Table 4

Accuracy of Individual FCI Comorbidities by Data Collection Method Compared to Complete Chart Review (n = 59)
FCI Comorbidity Prospective: Retrospective:
Admission Records Discharge Summaries
Sn Sp PPV NPV Sn Sp PPV NPV
Arthritis (rheumatoid and osteoarthritis) 14% 88% 25% 78% 14% 8% 4% 25%
Osteoporosis n/a n/a n/a n/a 0% 23% 0% 75%
Asthma 22% 52% 13% 68% 67% 24% 21% 70%
COPD, emphysema, or ARDS 0% 67% 0% 84% 63% 22% 9% 82%
Angina 0% 50% 0% 50% 0% 50% 0% 50%
Congestive heart failure (or heart disease) 50% 19% 4% 86% 67% 26% 9% 88%
Myocardial infarction 50% 21% 4% 86% 50% 59% 8% 94%
Neurological disease (e.g., MS or Parkinson’s) 0% 89% 0% 91% 100% 23% 11% 100%
Stroke or TIA 100% 17% 15% 100% 80% 40% 16% 93%
Peripheral vascular disease 25% 63% 8% 87% 75% 31% 12% 91%
Diabetes type I or II 50% 27% 7% 83% 50% 40% 9% 88%
Upper GI disease (e.g., ulcer, hernia, reflux) 8% 75% 8% 75% 80% 39% 26% 88%
Depression 17% 53% 8% 74% 56% 33% 16% 76%
Anxiety or panic disorders 0% 74% 0% 77% 67% 30% 17% 80%
Visual impairment (e.g., cataracts, glaucoma) n/a* n/a n/a n/a 0% 36% 0% 83%
Hearing impairment (e.g., hard of hearing with aids) n/a n/a n/a n/a n/a n/a n/a n/a
Degenerative disc disease (e.g., spinal stenosis) 0% 60% 0% 71% 60% 45% 21% 82%

Abbreviations: ARDS, acute respiratory distress syndrome; BMI, body mass index; COPD, chronic obstructive pulmonary disease; GI, gastrointestinal; MS, multiple sclerosis; NPV, negative predictive value; PPV, positive predictive value; Sn, sensitivity; Sp, specificity; TIA, transient ischemic attack.

* n/a if there were no instances of this comorbidity to calculate Sn, Sp, PPV, or NPV.

Fan et al.

Fan et al. BMC Anesthesiology 2012 12:21   doi:10.1186/1471-2253-12-21

Open Data